725 related articles for article (PubMed ID: 29204952)
1. [Therapeutic modulation of intestinal microbiota in irritable bowel syndrome. From probiotics to fecal microbiota therapy].
Konturek PC; Zopf Y
MMW Fortschr Med; 2017 Dec; 159(Suppl 7):1-5. PubMed ID: 29204952
[TBL] [Abstract][Full Text] [Related]
2. Fecal microbiota transplantation for managing irritable bowel syndrome.
El-Salhy M; Mazzawi T
Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):439-445. PubMed ID: 29493330
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
Harris LA; Baffy N
Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
[TBL] [Abstract][Full Text] [Related]
4. Progress with treating the microbial dysbiosis associated with irritable bowel syndrome.
Pearson JS; Whorwell PJ
Curr Opin Gastroenterol; 2017 Jan; 33(1):21-25. PubMed ID: 28134688
[TBL] [Abstract][Full Text] [Related]
5. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
Distrutti E; Monaldi L; Ricci P; Fiorucci S
World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286
[TBL] [Abstract][Full Text] [Related]
7. [Microbiota and irritable bowel syndrome: A critical inventory].
Enck P; Mazurak N
Z Gastroenterol; 2019 Jul; 57(7):859-870. PubMed ID: 31288282
[TBL] [Abstract][Full Text] [Related]
8. Nonpharmacologic options for treating irritable bowel syndrome.
Kay E; Hawramee S; Pollani S; Mandel ED
JAAPA; 2019 Mar; 32(3):38-42. PubMed ID: 30817479
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota and therapeutic approaches for dysbiosis in irritable bowel syndrome: recent developments and future perspectives.
Dale HF; Lied GA
Turk J Med Sci; 2020 Nov; 50(SI-2):1632-1641. PubMed ID: 32222124
[TBL] [Abstract][Full Text] [Related]
10. Dysbiosis in Irritable Bowel Syndrome.
Abraham P; Pratap N
J Assoc Physicians India; 2023 Sep; 71(9):75-81. PubMed ID: 38700306
[TBL] [Abstract][Full Text] [Related]
11. THE INTESTINAL MICROBIOTA AND THE ROLE OF PROBIOTICS IN IRRITABLE BOWEL SYNDROME: a review.
Moraes-Filho JP; Quigley EM
Arq Gastroenterol; 2015 Dec; 52(4):331-8. PubMed ID: 26840477
[TBL] [Abstract][Full Text] [Related]
12. Probiotics, prebiotics, and low FODMAP diet for irritable bowel syndrome - What is the current evidence?
Ooi SL; Correa D; Pak SC
Complement Ther Med; 2019 Apr; 43():73-80. PubMed ID: 30935559
[TBL] [Abstract][Full Text] [Related]
13. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics.
Principi N; Cozzali R; Farinelli E; Brusaferro A; Esposito S
J Infect; 2018 Feb; 76(2):111-120. PubMed ID: 29291933
[TBL] [Abstract][Full Text] [Related]
14. The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study.
Kurokawa S; Kishimoto T; Mizuno S; Masaoka T; Naganuma M; Liang KC; Kitazawa M; Nakashima M; Shindo C; Suda W; Hattori M; Kanai T; Mimura M
J Affect Disord; 2018 Aug; 235():506-512. PubMed ID: 29684865
[TBL] [Abstract][Full Text] [Related]
15. Probiotics, prebiotics, antibiotic, Chinese herbal medicine, and fecal microbiota transplantation in irritable bowel syndrome: Protocol for a systematic review and network meta-analysis.
He Y; Xu R; Wang W; Zhang J; Hu X
Medicine (Baltimore); 2020 Aug; 99(32):e21502. PubMed ID: 32769886
[TBL] [Abstract][Full Text] [Related]
16. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.
Gallo A; Passaro G; Gasbarrini A; Landolfi R; Montalto M
World J Gastroenterol; 2016 Aug; 22(32):7186-202. PubMed ID: 27621567
[TBL] [Abstract][Full Text] [Related]
17. Is irritable bowel syndrome an infectious disease?
Thompson JR
World J Gastroenterol; 2016 Jan; 22(4):1331-4. PubMed ID: 26819502
[TBL] [Abstract][Full Text] [Related]
18. Fecal Microbiota Transplant for Irritable Bowel Syndrome: Panacea or Placebo?
Shaukat A; Brenner DM
Am J Gastroenterol; 2019 Jul; 114(7):1032-1033. PubMed ID: 31082878
[TBL] [Abstract][Full Text] [Related]
19. Dysbiosis in Functional Bowel Disorders.
Enck P; Mazurak N
Ann Nutr Metab; 2018; 72(4):296-306. PubMed ID: 29694952
[TBL] [Abstract][Full Text] [Related]
20. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
